PTK2 and lung carcinoma: Collectively, these findings imply that inhalation of DP2 not only reinforces invasiveness of lung carcinoma cell via activation of integrin/FAK signaling but also may promote lung carcinoma metastasis via increasing production of tumor development mediators such as uPA, MMP-2, and IL-6.